Matches in Nanopublications for { ?s ?p "[hI-con1 molecule induces strong cytotoxicity against primary chemotherapy-resistant ovarian cancer cell lines overexpressing TF and may represent a novel therapeutic agent for the treatment of ovarian tumors refractory to standard treatment modalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion description "[hI-con1 molecule induces strong cytotoxicity against primary chemotherapy-resistant ovarian cancer cell lines overexpressing TF and may represent a novel therapeutic agent for the treatment of ovarian tumors refractory to standard treatment modalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion description "[hI-con1 molecule induces strong cytotoxicity against primary chemotherapy-resistant ovarian cancer cell lines overexpressing TF and may represent a novel therapeutic agent for the treatment of ovarian tumors refractory to standard treatment modalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.